It appears that most private companies look at how their health insurance plans impact their budgets rather than how they ...

As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...

"I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.

UnitedHealth CEO Andrew Witty’s recent public comments suggest he understands healthcare’s biggest problem. The question is: Will he take action to fix it?

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Better Health Partnership will administer a new program designed to increase lead screening and testing rates in Cleveland.

The Pittsburgh region has seen more than its share of commercialized safety innovations that have been born and bred in our ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

Quest Diagnostics is a leading provider of independent diagnostic testing in the United States thanks to its network of roughly 2,300 patient service centers across the country. We think its size and ...

GENEVA--(BUSINESS WIRE)--medimaps group S.A., a global leader in ... TBS Osteo complements bone mineral density measurements and clinical risk factors, providing clinicians with a comprehensive tool ...